WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy

Not Applicable

Terminated

Conditions: Brain Cancer
Head and Neck Cancer
Lung Cancer

Interventions: Device: Siemens Somatom Definition Edge
Device: Philips Brilliance Big Bore CT/simulator

First Posted Date: 2018-01-18

Last Posted Date: 2024-03-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 36

Registration Number: NCT03403361

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Hormonal Contraceptive Health Education for Adolescent Males

Not Applicable

Completed

Conditions: Contraception Behavior

Interventions: Behavioral: Education Arm

First Posted Date: 2018-01-17

Last Posted Date: 2024-03-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 107

Registration Number: NCT03400410

Locations: 🇺🇸
Washington Univeristy at St Louis, Saint Louis, Missouri, United States

Low Dialysate Temperature During SLED

Not Applicable

Completed

Conditions: Acute Kidney Injury
Intra-dialytic Hypotension

Interventions: Other: Changing dialysate temperature

First Posted Date: 2018-01-12

Last Posted Date: 2018-01-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 38

Registration Number: NCT03397992

Cognitive Flexibility Training in Persistent Pain

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Training

First Posted Date: 2018-01-12

Last Posted Date: 2020-05-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 150

Registration Number: NCT03398408

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Nutraceutical Efficacy for rUTI

Phase 2

Terminated

Conditions: Urinary Tract Infections

Interventions: Drug: D-Mannose

First Posted Date: 2018-01-10

Last Posted Date: 2022-02-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 61

Registration Number: NCT03395288

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Palbociclib
Drug: Cisplatin
Drug: Cetuximab
Radiation: Intensity-Modulated Radiation Therapy
Procedure: Tumor biopsy
Procedure: Peripheral blood draw

First Posted Date: 2018-01-03

Last Posted Date: 2025-04-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT03389477

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Phase 4

Completed

Conditions: Diarrhea
Clostridium Difficile Infection

Interventions: Drug: Oral Vancomycin
Drug: Placebo
Device: Toxin enzyme immunoassay
Device: Nuceleic acid amplification test

First Posted Date: 2018-01-02

Last Posted Date: 2021-07-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT03388268

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

Phase 2

Completed

Conditions: Antibody-mediated Rejection
Lung Transplant Rejection

Interventions: Drug: Tacrolimus
Drug: Belatacept
Drug: ATG
Drug: Mycophenolate Mofetil
Drug: Methylprednisolone
Drug: Prednisone

First Posted Date: 2018-01-02

Last Posted Date: 2022-11-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT03388008

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis

Phase 1

Terminated

Conditions: Myelofibroses

Interventions: Drug: Pevonedistat
Drug: Ruxolitinib
Procedure: Peripheral blood draw
Procedure: Skin biopsy

First Posted Date: 2017-12-29

Last Posted Date: 2022-01-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT03386214

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

Not Applicable

Terminated

Conditions: Embryo Transfer
Assisted Reproductive Technology
Antibiotic Prophylaxis

Interventions: Other: Withholding antibiotic prophylaxis

First Posted Date: 2017-12-29

Last Posted Date: 2020-08-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT03386227

Locations: 🇺🇸
Washington University Reproductive Endocrinology, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy